首页> 美国卫生研究院文献>Microorganisms >Detection of Increased Relative Expression Units of Bacteroides and Prevotella and Decreased Clostridium leptum in Stool Samples from Brazilian Rheumatoid Arthritis Patients: A Pilot Study
【2h】

Detection of Increased Relative Expression Units of Bacteroides and Prevotella and Decreased Clostridium leptum in Stool Samples from Brazilian Rheumatoid Arthritis Patients: A Pilot Study

机译:从巴西类风湿性关节炎患者的粪便样品中检出的拟杆菌和小球藻的相对表达单位增加以及瘦梭状芽胞杆菌的检测:一项初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Interactions between gut microbes and disease modifying antirheumatic drugs (DMARDs) have been proposed. The aim of the present study was to evaluate the presence of some specific bacteria in stool samples from Brazilian RA patients receiving DMARDs and correlate these data with diet, clinical parameters, and cytokines. Stool samples were used for gut bacteria evalutation by qPCR. Serum samples were used to quantify IL-4 and IL-10 by flow cytometer. Statistics were performed by Pearson chi-square, Mann–Whitney U test, and Spearman’s correlation. The study included 20 RA patients and 30 healthy controls. There were no significant differences ( > 0.05) in dietary habits between RA patients and controls. Concerning gut bacteria, we observed an increase in relative expression units (REU) of and species in stool samples from patients, and a decrease in REU of when compared with healthy controls. Positive correlation between and rheumatoid factor was detected. The IL-4 and IL-10 concentrations were increased in patients when compared with controls. We concluded that gut bacteria are different between RA patients receiving DMARDs and healthy controls. Further studies are necessary to determine the real role of gut microbes and their metabolities in clinical response to different DMARDs in RA patients.
机译:已经提出了肠道微生物与抗风湿药(DMARDs)之间的相互作用。本研究的目的是评估接受DMARD的巴西RA患者粪便样品中某些特定细菌的存在,并将这些数据与饮食,临床参数和细胞因子相关联。大便样品用于通过qPCR对肠细菌进行评估。血清样品用于通过流式细胞仪定量IL-4和IL-10。统计数据通过Pearson卡方检验,Mann-Whitney U检验和Spearman的相关性进行。该研究包括20名RA患者和30名健康对照。 RA患者和对照组之间的饮食习惯没有显着差异(> 0.05)。关于肠道细菌,我们观察到患者粪便样品的相对表达单位(REU)和种类的增加,而与健康对照相比,REU的减少。检测到与类风湿因子之间呈正相关。与对照组相比,患者的IL-4和IL-10浓度升高。我们得出的结论是,接受DMARDs治疗的RA患者和健康对照组的肠道细菌有所不同。需要进一步的研究来确定肠道微生物及其代谢物在RA患者对不同DMARDs的临床反应中的真正作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号